Metabolic disorders such as obesity and type 2 diabetes are one of the most familiar risk factors in the present time among every age-group. It is associated with altered levels of adipokines such as adiponectin, chemerin, leptin, resistin, visfatin, and so on. Adiponectin is one of the adipocyte-specific protein with novel applications pertaining to metabolism by promoting insulin sensitivity and regulating glucose and fatty acid catabolism, while chemerin is considered as an inhibitor of insulin signaling and glucose catabolism. Other than these established functions, both the adipokines are intimately involved in coordinating reproductive activities, but they exhibit contrary functions. This review is an amalgamation of recent information related to adiponectin and chemerin in male and female reproduction and further its association with metabolism-related reproductive disorders. The direct effect of adiponectin and chemerin on various reproductive parameters has been investigated, but there was a rampant failure to account for in vivo data which gives a broad outlook on the regulatory mechanism of both adiponectin and chemerin related to male and female reproductive functions. Adiponectin is known to promote gonadal activities, while chemerin exerts antigonadal actions. Recent research suggests that high chemerin/low adiponectin ratio plays a vital role in causing dyslipidemia and metabolic syndrome in patients. The dysregulated ratio of adiponectin to chemerin during various metabolic disorders makes it really worthy in relation to an application for therapeutics. Still, a lot regarding both the adipokines has to be explored and brought forward in order to deal with therapeutics of metabolism-related reproductive disorders.
MogesBAmareBFantahunBKassuA. High prevalence of overweight, obesity, and hypertension with increased risk to cardiovascular disorders among adults in northwest Ethiopia: a cross sectional study. BMC Cardiovascu Disord. 2014;14:155.
2.
CoelhoMOliveiraTFernandesR. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013;9(2):191–200.
3.
ReverchonMRaméCBertoldoMDupontJ. Adipokines and the female reproductive tract. Int J Endocrinol. 2014;2014:232454.
4.
RakAMelloukNFromentP. Adiponectin and resistin: potential metabolic signals affecting hypothalamo-pituitary gonadal axis in females and males of different species. Reproduction. 2017;153(6):R215–R226.
5.
YamauchiTKamonJWakiH. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7(8):941–946.
6.
YamauchiTKamonJMinokoshiY. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8(11):1288–1295.
7.
BergAHCombsTPDuXBrownleeMSchererPE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7(8):947–953.
8.
StefanNStumvollM. Adiponectin—its role in metabolism and beyond 24. Horm Metab Res. 2002;34(9):469–474.
9.
Brochu-GaudreauKRehfeldtCBlouinRBordignonVMurphyBDPalinMF. Adiponectin action from head to toe. Endocrine. 2010;37(1):11–32.
10.
OkamotoY. Adiponectin provides cardiovascular protection in metabolic syndrome. Cardiol Res Pract. 2011;2011:313179.
11.
YamauchiTKadowakiT. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab. 2013;17(2):185–196.
12.
ComninosANJayasenaCNDhilloWS. The relationship between gut and adipose hormones, and reproduction. Hum Reprod Update. 2014;20(2):153–174.
13.
BondueBWittamerVParmentierM. Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine Growth Factor Rev. 2011;22(5-6):331–338. doi:10.1016/j.cytogfr.2011.11.004
14.
WeyerCFunahashiTTanakaS. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930–1935.
15.
HoffstedtJArvidssonESjölinEWåhlénKArnerP. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab. 2004;89(3):1391–136.
16.
KimDHKimCDingELTownsendMKLipsitzLA. Adiponectin levels and the risk of hypertension: a systematic review and meta-analysis. Hypertension. 2013;62(1):27–32.
17.
KimHSJoJLimJE. Adiponectin as predictor for diabetes among pre-diabetic groups. Endocrine. 2013;44(2):411–418.
18.
ChuSHLeeMKAhnKY. Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PLoS One. 2012;7(4):e34710.
19.
SchererPEWilliamsSFoglianoMBaldiniGLodishHF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270(45):26746–26750.
20.
HuELiangPSpiegelmanBM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996;271(18):10697–10703.
21.
MaedaKOkuboKShimomuraIFunahashiTMatsuzawaY, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun. 1996;221(2):286–289.
22.
NakanoYTobeTChoi-MiuraNHMazdaTTomitaM. Isolation and characterization of GBP28: a novel gelatin-binding protein purified from human, plasma. J Biochem. 1996;120(4):803–812.
23.
YamauchiTKamonJItoY. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003;423(6941):762–769.
24.
YamauchiTNioYMakiT. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med. 2007;13(3):332–339.
25.
NagpalSPatelSJacobeH. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol. 1997;109(1):91–95.
26.
MarcheseADochertyJM, Nguyen T, et al.Cloning of human genes encoding novel G protein-coupled receptors. Genomics. 1994;23(3):609–618.
27.
BarneaGStrappsWHerradaG. The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci U S A. 2008;105(1):64–69.
28.
GantzIKondaYYangYKMillerDEDierickHAYamadaT. Molecular cloning of a novel receptor (CMKLR1) with homology to the chemotactic factor receptors. Cytogenet Cell Genet. 1996;74(4):286–90.
29.
FanPKyawHSuK. Cloning and characterization of a novel human chemokine receptor. Biochem Biophys Res Commun. 1998;243(1):264–268.
30.
ZabelBANakaeSZunigaL. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med. 2008;205(10):2207–2220.
31.
RuanHDongLQ. Adiponectin signaling and function in insulin target tissues. J Mol Cell Biol. 2016;8(2):101–109.doi:10.1093/jmcb/mjw014
32.
AritaYKiharaSOuchiN. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257(1):79–83.
33.
SieminskaLMarekBKos-KudlaB. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters. J Endocrinol Invest. 2004;27(6):528–534.
34.
YangWSLeeWJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86(8):3815–3819.
35.
PajvaniUBDuXCombsTP. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: implications for metabolic regulation and bioactivity. J Biol Chem. 2003;278(11):9073–9085.
36.
WakiHYamauchiTKamonJ. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem. 2003;278(41):40352–40363.
37.
PajvaniUBHawkinsMCombsTP. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004;279(13):12152–12162.
38.
MiyazakiTBubJDUzukiMIwamotoY. Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem Biophys Res Commun. 2005;333(1):79–87.
39.
CeddiaRBSomwarRMaidaAFangXBikopoulosGSweeneyG. Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia. 2005;48(1):132–139.
40.
FangXPalanivelRZhouX. Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts. J Mol Endocrinol. 2005;35(3):465–476.
41.
FruebisJTsaoTJavorschiS. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 2001;98(4):2005–2010.
42.
MatternAZellmannTBeck-SickingerAG. Processing, signaling, and physiological function of chemerin. IUBMB Life. 2014;66(1):19–26.
43.
ZabelBAZunigaLOhyamaT. Chemoattractants, extracellular proteases, and the integrated host defense response. Exp Hematol. 2006;34(8):1021–1032.
44.
FatimaSSRehmanRBaigMKhanTA. New roles of the multidimensional adipokine: chemerin. Peptides. 2014;62:15–20.
45.
BozaogluKBoltonKMcMillanJ. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 2007;148(10):4687–4694.
46.
CoimbraSBrandão ProençaJSantos-SilvaANeuparthMJ. Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease. BioMed Res Int. 2014;2014:701915.
47.
TangYTHuTArterburnM. PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif. J Mol Evol. 2005;61(3):372–380.
48.
TanabeHFujiiYOkada-IwabuM. Crystal structures of the human adiponectin receptors. Nature. 2015;520(7547):312–316.
49.
CamposDBPalinM-FBordignonVMurphyBD. The “beneficial” adipokines in reproduction and fertility. Int J Obes (Lond). 2008;32(2):223–231.
50.
MatsunamiTSatoYArigaS. Regulation of oxidative stress and inflammation by hepatic adiponectin receptor 2 in an animal model of nonalcoholic steatohepatitis. Int J Clin Exp Pathol. 2010;3(5):472–481.
51.
YoshimuraTOppenheimJJ. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2): two multifunctional receptors with unusual properties. Exp Cell Res. 2011;317(5):674–684. doi:10.1016/j.yexcr.2010.10.023
52.
MonnierJLewenSO’HaraEHuangKTuHButcherEC. Expression, regulation, and function of atypical chemerin receptorCCRL2 on endothelial cells. J Immunol. 2012;189(2):956–967. doi:10.4049/jimmunol.1102871
53.
HelferGRossAWThomsonLM. A neuroendocrine role for chemerin in hypothalamic remodelling and photoperiodic control of energy balance. Sci Rep. 2016;6:26830.
54.
CombsTPBergAHRajalaMW. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes. 2003;52(2):268–276.
55.
NagasawaAFukuiKFunahashiT. Effects of soy protein diet on the expression of adipose genes and plasma adiponectin. Horm Metab Res. 2002;34(11-12):635–639.
56.
FlachsPMohamed-AliVHorakovaO. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia. 2006;49(2):394–397.
57.
NagaoKInoueNWangYMYanagitaT. Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats. Biochem Biophys Res Commun. 2003;310(2):562–566.
58.
MelloukNRameCMarchandM. Effect of different levels of feed restriction and fish oil fatty acid supplementation on fat deposition by using different techniques, plasma levels and mRNA expression of several adipokines in broiler breeder hens. PLoS One. 2018;13(1):e0191121.
59.
ChabrolleCToscaLCrochetSTesseraudSDupontJ. Expression of adiponectin and its receptors (AdipoR1 and AdipoR2) in chicken ovary: potential role in ovarian steroidogenesis. Domest Anim Endocrinol. 2007;33(4):480–487.
60.
ChabrolleCToscaLDupontJ. Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis. Reproduction. 2007;133(4):719–731.
61.
ComimF V.HardyKFranksS. Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome. PLoS One. 2013;8(11):e80416.
62.
SinghABoraPKrishnaA. Direct action of adiponectin ameliorates increased androgen synthesis and reduces insulin receptor expression in the polycystic ovary. Biochem Biophys Res Commun. 2017;488(3):509–515.
LordELedouxSMurphyBDBeaudryDPalinMF. Expression of adiponectin and its receptors in swine. J Anim Sci. 2005;83(3):565–578.
65.
LagalyDVAadPYGrado-AhuirJAHulseyLBSpicerLJ. Role of adiponectin in regulating ovarian theca and granulosa cell function. Mol Cell Endocrinol. 2008;284(1-2):38–45. doi:10.1016/j.mce.2008.01.007
66.
MaillardVUzbekovaSGuignotFPerreauCRaméCCoyral-castelS. Effect of adiponectin on bovine granulosa cell steroidogenesis, oocyte maturation and embryo development. Reprod Biol Endocrinol. 2010;8:23. doi:10.1186/1477-7827-8-23
67.
SinghAKrishnaA. Localization of adiponectin and its receptor and its possible roles in the ovary of a vespertilionid bat, Scotophilus heathi. Gen Comp Endocrinol. 2012;176(2):240–251. doi:10.1016/j.ygcen.2012.01.020
68.
OliveiraBSPCostaJASGomesET. Expression of adiponectin and its receptors ( AdipoR1 and AdipoR2 ) in goat ovary and its effect on oocyte nuclear maturation in vitro. Theriogenology. 2017;104:127–133.
69.
ChabrolleCToscaLRaméCLecomtePRoyèreDDupontJ. Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells. Fertil Steril. 2009;92(6):1988–1996.
70.
TabandehMRHosseiniASaebMKafiMSaebS. Changes in the gene expression of adiponectin and adiponectin receptors (AdipoR1 and AdipoR2) in ovarian follicular cells of dairy cow at different stages of development. Theriogenology. 2010;73(5):659–669.
71.
ChengLShiHJinY. Adiponectin deficiency leads to female subfertility and ovarian dysfunctions in mice. Endocrinology. 2016;157(12):4875–4887.
72.
GutmanGBarakVMaslovitzSAmitALessingJBGevaE. Recombinant luteinizing hormone induces increased production of ovarian follicular adiponectin in vivo: implications for enhanced insulin sensitivity. Fertil Steril. 2009;91(5):1837–1841.
73.
SinghAKrishnaA. Effects of adiponectin on ovarian folliculogenesis and steroidogenesis in the vespertilionid bat, Scotophilus heathi. Gen Comp Endocrinol. 2012;178(3):502–510. doi:10.1016/j.ygcen.2012.06.027
74.
TakemuraYOsugaYYamauchiT. Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology. 2006;147(7):3203–3210.
75.
CaminosJENogueirasRGallegoR. Expression and regulation of adiponectin and receptor in human and rat placenta. J Clin Endocrinol Metabolism. 2005;90(7):4276–4286.
76.
ChenJTanBKarterisE. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia. 2006;49(6):1292–1302.
77.
LappasMYeeKPermezelMRiceGE. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol. 2005;186(3):457–465.
78.
McDonaldEAWolfeMW. Adiponectin attenuation of endocrine function within human term trophoblast cells. Endocrinology. 2009;150(9):4358–4365.
79.
KimSTMarquardKStephensSLoudenEAllsworthJMoleyKH. Adiponectin and adiponectin receptors in the mouse preimplantation embryo and uterus. Hum Reprod. 2011;26(1):82–95.
80.
PierrePFromentPNgreD. Role of adiponectin receptors, AdipoR1 and AdipoR2, in the steroidogenesis of the human granulosa tumor cell line, KGN. Hum Reprod. 2009;24(11):2890–2901.
81.
KimJYXueKCaoM. Chemerin suppresses ovarian follicular development and its potential involvement in follicular arrest in rats treated chronically with dihydrotestosterone. Endocrinology. 2013;154(8):2912–2923.
82.
ReverchonMCornuauMRamCGuerifFRoyreDDupontJ. Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells. Hum Reprod. 2012;27(6):1790–1800.
83.
ReverchonMBertoldoMJRaméCFromentPDupontJ. CHEMERIN (RARRES2) decreases in vitro granulosa cell steroidogenesis and blocks oocyte meiotic progression in bovine species. Biol Reprod. 2014;90(5):102. doi:10.1095/biolreprod.113.117044
84.
YangYLRenLRSunLF. The role of GPR1 signaling in mice corpus luteum. J Endocrinol. 2016;230(1):55–65.
85.
DiotMReverchonMRameC. Expression of adiponectin, chemerin and visfatin in plasma and different tissues during a laying season in turkeys. Reprod Biol Endocrinol. 2015;13:1–14.
86.
GarcesMFSanchezEAcostaBJ. Expression and regulation of chemerin during rat pregnancy. Placenta. 2012;33(5):373–378.
87.
CarlinoCTrottaEStabileH. Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancy. J Clin Endocrinol Metab. 2012;97(10):3603–3612. doi:10.1210/jc.2012-1102
88.
WangQKimJYXueKLiuJYLeaderATsangBK. Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome. Endocrinology. 2012;153(11):5600–5611.
89.
Ocón-GroveOMKrzysik-WalkerSMMaddineniSRHendricksGLRamachandranR. Adiponectin and its receptors are expressed in the chicken testis: influence of sexual maturation on testicular ADIPOR1 and ADIPOR2 mRNA abundance. Reproduction. 2008;136(5):627–638. doi:10.1530/REP-07-0446
90.
CaminosJENogueirasRGaytaFPinedaRGonzaCR. Novel expression and direct effects of adiponectin in the rat testis. Endocrinology. 2008;149(7):3390–3402.
91.
RahmanifaraFTabandehbMR. Adiponectin and its receptors gene expression in the reproductive tract of Ram. Small Ruminant Res. 2012;105:263–267.
92.
CivitareseAEJenkinsonCPRichardsonD. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of type 2 diabetes. Diabetologia. 2004;47(5):816–820.
93.
KasimanickamVRKasimanickamRKKastelicJPStevensonJS. Associations of adiponectin and fertility estimates in Holstein bulls. Theriogenology. 2013;79(5):766–777.
94.
BjursellMAhnmarkABohloolyYM. Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes. 2007;56(3):583–593.
SchäfflerASchölmerichJSalzbergerB. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends in Immunology. 2007;28(9):393–399.
97.
WuLXuBFanWZhuXWangGZhangA. Adiponectin protects Leydig cells against proinflammatory cytokines by suppressing the nuclear factor-κB signaling pathway. FEBS J. 2013;280(16):3920–3927.
98.
HongCYParkJHAhnRS. Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha. Mol Cell Biol. 2004;24(7):2593–2604.
99.
PfaehlerANanjappaMKColemanES. Regulation of adiponectin secretion by soy isoflavones has implication for endocrine function of the testis. Toxicology Lett. 2012;209(1):78–85.
100.
LandryDParéAJeanSMartinLJ. Adiponectin influences progesterone production from MA-10 Leydig cells in a dose-dependent manner. Endocrine. 2015;48(3):957–967.
101.
JonesR. Plasma membrane structure and remodelling during sperm maturation in the epididymis. J Reprod Fertil. 1998;53:73–84.
102.
MarengoSR.Maturing the sperm: unique mechanisms for modifying integral proteins in the sperm plasma membrane. Animal Reprod Sci. 2008;105(1-2):52–63.
103.
WittamerVFranssenJDVulcanoM. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med. 2003;198(7):977–985.
104.
TakahashiMOkimuraYIguchiG. Chemerin regulates β-cell function in mice. Sci Rep. 2011;1:123.
105.
LiLMaPHuangC. Expression of chemerin and its receptors in rat testes and its action on testosterone secretion. J Endocrinol. 2014;220(2):155–163.
Escobar-MorrealeHFVilluendasGBotella-CarreteroJI. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod. 2006;21(9):2257–2265.
108.
OrioFPalombaSCascellaT. Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2003;88:2619–2623.
109.
PanidisDKourtisAFarmakiotisDMouslechTRoussoDKoliakosG. Serum adiponectin levels in women with polycystic ovary syndrome. Hum Reprod. 2003;18(9):1790–1796.
110.
CarminaEOrioFPalombaS. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol. 2005;152(3):389–394.
111.
BenrickAChanclónBMicallefPWuYHadiLSheltonJM. Adiponectin protects against development of metabolic disturbances in a PCOS mouse model. Proc Natl Acad Sci U S A. 2017;114(34):E7187–E7196. doi:10.1073/pnas.1708854114
112.
SinghABoraPKrishnaA. Systemic adiponectin treatment reverses polycystic ovary syndrome-like features in an animal model. Reprod Fertil Dev. 2017;30(4):571–584. doi:10.1071/RD17255
113.
KrishnaA. Modulation of ovarian steroidogenesis by adiponectin during delayed embryonic development of Cynopterus sphinx. J Steroid Biochem Mol Biol. 2014;143:291–305. doi:10.1016/j.jsbmb.2014.04.009
114.
AnuradhaKrishna A. Role of adiponectin in delayed embryonic development of the short-nosed fruit bat, Cynopterus sphinx. Mol Reprod Dev. 2014;81(12):1086–1102. doi:10.1002/mrd.22425
115.
Dal MasoLAugustinLSAKaralisA. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metabol. 2004;89(3):1160–1163.
116.
MartinLJ. Implications of adiponectin in linking metabolism to testicular function. Endocrine. 2014;46(1):16–28. doi:10.1007/s12020-013-0102-0
117.
BaiJLiuYNiuGF. Relationship between adiponectin and testosterone in patients with type 2 diabetes. Biochem Med (Zagreb). 2011;21(1):65–70.
118.
KashouAHdu PlessisSSAgarwalA. The Role of Obesity in ROS Generation and Male Infertility. In: AgarwalAAitkenRAlvarezJ, eds, Studies on Men's Health and Fertility. Oxidative Stress in Applied Basic Research and Clinical Practice. New York, NY: Humana Press, c/o Springer Science+Business Media, LLC.; 2012;571–590.
119.
GuoZYanXWangLWuJJingXLiuJ. Effect of telmisartan or insulin on the expression of adiponectin and its receptors in the testis of streptozotocin-induced diabetic rats. Horm Metab Res. 2016;48(6):404–412. doi:10.1055/s-0042-101549
120.
RatoMLGAlvesSSocorroJE. Metabolic regulation is important for spermatogenesis. Nat Rev Urol. 2012;9(6):330–338.
121.
KawwassJFSummerRKallenCB. Direct effects of leptin and adiponectin on peripheral reproductive tissues: a critical review. Mol Hum Reprod. 2015;21(8):617–632.
122.
FuSXuHGuM. Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity. Sci Rep. 2017;7:43771–43715. doi:10.1038/srep43771
123.
WangQLeaderATsangBK. Inhibitory roles of prohibitin and chemerin in FSH-induced rat granulosa cell steroidogenesis. Endocrinology. 2013;154(2):956–967.
124.
KortDHKostoliasASullivanCLoboRA. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol. 2014;3590:1–4.
125.
TanBKChenJFarhatullahS. Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes. 2009;58(9):1971–1977.
126.
TalSSeiferDBAriciA. The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome. Semin Reprod Med. 2015;33(3):195–207
127.
BozaogluKCurranJEStockerCJZaibiMSSegalDKonstantopoulosN. Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab. 2010;95(5):2476–2485. doi:10.1210/jc.2010-0042
128.
KabiriNTabandehMTabatabaieSR. Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation. DARU. 2014;22:39
129.
JialalIDevarajSKaurHAdams-HuetBBremerAA. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab. 2013;98(3):E514–E517.
130.
WeigertJNeumeierMWanningerJ. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf). 2010;72(3):342–348.
131.
FatimaSSBozaogluKRehmanRAlamFMemonAS. Elevated chemerin levels in Pakistani men: an interrelation with metabolic syndrome phenotypes. PLoS One. 2013;8(2):e57113.
